In Vitro Fertilization Market Size, Share, Growth Analysis 2031
In Vitro
Fertilization has revolutionized reproductive healthcare by offering a
solution to couples facing infertility. The IVF market has witnessed
significant growth in recent years due to advancements in medical technology,
increasing awareness of fertility treatments, and changing societal trends. As
the demand for fertility treatments continues to rise globally, the IVF market
is expected to experience substantial expansion in the coming years.
As of 2023, the global IVF market was valued at
approximately USD 26.09 billion. The market is projected to grow at a compound
annual growth rate (CAGR) of 7.79% from 2024 to 2031, reaching an estimated
value of USD 47.54 billion by 2031. This growth can be attributed to several
key factors that are influencing the demand for IVF services globally.
To Learn More About This Report, Request a Free Sample
Copy - https://www.skyquestt.com/sample-request/in-vitro-fertilization-market
Key Drivers of Market Growth
1. Rising Incidence of Infertility - The global
infertility rate has seen a significant rise in recent years. Factors such as
delayed childbearing, lifestyle changes, and rising environmental pollution
have contributed to an increase in fertility problems. According to the World
Health Organization (WHO), approximately 10-15% of couples worldwide experience
infertility. This increasing prevalence of infertility is expected to drive
demand for IVF treatments, particularly in developed countries with advanced
healthcare systems.
2. Technological Advancements in IVF Procedures -
Technological innovation in IVF procedures, such as genetic screening,
cryopreservation, and improved embryo culture media, has contributed to higher
success rates and lower treatment costs. New developments, including genetic
testing (PGT-A), have made it possible to select the healthiest embryos for
implantation, improving success rates and reducing the risk of genetic
disorders.
3. Increase in Awareness and Acceptance of Fertility
Treatments - As awareness about infertility and assisted reproductive
technologies (ART) grows, more couples are opting for IVF treatments. Public
education campaigns, online resources, and social media have played a
significant role in reducing the stigma surrounding fertility treatments. In
many countries, IVF is now widely accepted as a standard medical procedure for
treating infertility.
4. Availability of Fertility Clinics and Healthcare
Infrastructure - The proliferation of specialized fertility clinics
worldwide has made IVF treatments more accessible to a broader population. Many
clinics offer various IVF packages and financing options, making the procedure
more affordable for individuals across different socioeconomic backgrounds.
Furthermore, countries like the U.S., the UK, India, and others have seen a
rise in medical tourism, where patients travel abroad to undergo IVF at lower
costs.
5. Advances in Stem Cell Research and Cryopreservation
- Innovations in stem cell research and cryopreservation techniques have
significantly improved IVF outcomes. Techniques like egg and embryo freezing
allow women to preserve their fertility, providing them with more options for
later pregnancy. These advances in reproductive medicine are expected to
contribute to market expansion.
6. Government Support and Insurance Coverage - Some
countries have implemented policies to subsidize fertility treatments,
increasing access to IVF. For example, several European nations, such as
Denmark and France, offer state-funded IVF treatments or significant insurance
coverage for fertility procedures. Such initiatives are expected to boost
market growth in these regions.
Market Segmentation
- By Type:
- Fresh IVF Cycles
- Frozen IVF Cycles
- By End-User:
- Fertility Clinics
- Hospitals
- Surgical Centers
- By Treatment:
- ICSI
(Intracytoplasmic Sperm Injection)
- PGT
(Preimplantation Genetic Testing)
- Egg/sperm
Donation IVF
- Embryo
Cryopreservation
- By Gender:
- Female
Infertility
- Male Infertility
Top Player’s Company Profiles in Global In Vitro
Fertilization Market - Vitrolife AB, Cook Medical, Merck KGaA, Thermo
Fisher Scientific, Inc., Esco Micro Pte Ltd, Genea Limited, Ferring
Pharmaceuticals, Hamilton Thorne, Inc., Nidacon International AB, Rocket
Medical plc, EMD Serono, Kitazato Corporation, IVFtech Aps, Zeiss Group,
Labotect GmbH, Esco Medical, The Baker Company, Inc., Boston IVF, Invitrocare
Fertility Laboratories Pvt. Ltd., EMD Serono, Inc., Fujifilm Holdings
Corporation
Read In Vitro Fertilization Market Report Today - https://www.skyquestt.com/report/in-vitro-fertilization-market
Comments
Post a Comment